Cargando…
Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model
BACKGROUND: Malignant pleural effusion (MPE) is a frequent complication of advanced malignancies that leads to a poor quality of life and limits treatment options. OBJECTIVE: The objective of this study was to identify biomarkers of survival in patients with MPE, which will greatly facilitate the cl...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214552/ https://www.ncbi.nlm.nih.gov/pubmed/34163245 http://dx.doi.org/10.2147/CMAR.S305223 |
_version_ | 1783710088054177792 |
---|---|
author | Zhang, Xin Yi, Feng-Shuang Shi, Huan-Zhong |
author_facet | Zhang, Xin Yi, Feng-Shuang Shi, Huan-Zhong |
author_sort | Zhang, Xin |
collection | PubMed |
description | BACKGROUND: Malignant pleural effusion (MPE) is a frequent complication of advanced malignancies that leads to a poor quality of life and limits treatment options. OBJECTIVE: The objective of this study was to identify biomarkers of survival in patients with MPE, which will greatly facilitate the clinical management of this complication. METHODS: This retrospective study recruited patients who had been pathologically diagnosed with MPE, regardless of the type of primary cancer, at Beijing Chao-Yang Hospital over 158 months. Demographic, clinical, hematological, and pleural fluid data were collected and analyzed as potential predictors of survival, and a new predictive model was developed based on Cox and logistic regression analyses. RESULTS: In our alternative prognostic model (n = 281), four routinely detected variables, namely, carcinoembryonic antigen (CEA) level, monocyte count, N-terminal pro B-type natriuretic peptide (NT-pro-BNP) level, and pleural effusion chloride level on admission, were identified as predictors (the CONCH prognostic score). Patients were divided into three prognosis subgroups based on risk stratification, with median survival periods of 17, 11, and 5 months, respectively. In comparison with the low-risk group, patients in the medium- and high-risk groups showed significantly poorer survival (medium-risk group: hazard ratio [HR], 1.586; 95% confidence interval [CI], 1.047–2.402; P = 0.029; high-risk group: HR, 4.389; 95% CI, 2.432–7.921; P < 0.001). CONCLUSION: Four routinely detected variables were used to develop the CONCH scoring system, which was confirmed to be an accurate prognostic score for patients with MPE. This system can guide the selection of interventions and management for MPE. |
format | Online Article Text |
id | pubmed-8214552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82145522021-06-22 Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model Zhang, Xin Yi, Feng-Shuang Shi, Huan-Zhong Cancer Manag Res Original Research BACKGROUND: Malignant pleural effusion (MPE) is a frequent complication of advanced malignancies that leads to a poor quality of life and limits treatment options. OBJECTIVE: The objective of this study was to identify biomarkers of survival in patients with MPE, which will greatly facilitate the clinical management of this complication. METHODS: This retrospective study recruited patients who had been pathologically diagnosed with MPE, regardless of the type of primary cancer, at Beijing Chao-Yang Hospital over 158 months. Demographic, clinical, hematological, and pleural fluid data were collected and analyzed as potential predictors of survival, and a new predictive model was developed based on Cox and logistic regression analyses. RESULTS: In our alternative prognostic model (n = 281), four routinely detected variables, namely, carcinoembryonic antigen (CEA) level, monocyte count, N-terminal pro B-type natriuretic peptide (NT-pro-BNP) level, and pleural effusion chloride level on admission, were identified as predictors (the CONCH prognostic score). Patients were divided into three prognosis subgroups based on risk stratification, with median survival periods of 17, 11, and 5 months, respectively. In comparison with the low-risk group, patients in the medium- and high-risk groups showed significantly poorer survival (medium-risk group: hazard ratio [HR], 1.586; 95% confidence interval [CI], 1.047–2.402; P = 0.029; high-risk group: HR, 4.389; 95% CI, 2.432–7.921; P < 0.001). CONCLUSION: Four routinely detected variables were used to develop the CONCH scoring system, which was confirmed to be an accurate prognostic score for patients with MPE. This system can guide the selection of interventions and management for MPE. Dove 2021-06-14 /pmc/articles/PMC8214552/ /pubmed/34163245 http://dx.doi.org/10.2147/CMAR.S305223 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhang, Xin Yi, Feng-Shuang Shi, Huan-Zhong Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model |
title | Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model |
title_full | Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model |
title_fullStr | Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model |
title_full_unstemmed | Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model |
title_short | Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model |
title_sort | predicting survival for patients with malignant pleural effusion: development of the conch prognostic model |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214552/ https://www.ncbi.nlm.nih.gov/pubmed/34163245 http://dx.doi.org/10.2147/CMAR.S305223 |
work_keys_str_mv | AT zhangxin predictingsurvivalforpatientswithmalignantpleuraleffusiondevelopmentoftheconchprognosticmodel AT yifengshuang predictingsurvivalforpatientswithmalignantpleuraleffusiondevelopmentoftheconchprognosticmodel AT shihuanzhong predictingsurvivalforpatientswithmalignantpleuraleffusiondevelopmentoftheconchprognosticmodel |